Terry Fullerton is an experienced clinical development professional with a strong background in the pharmaceutical industry. Serving as Vice President of Clinical Development at Pfizer since May 2023, Terry previously held the positions of Executive Director and Senior Director in Clinical Development, focusing on Neurosciences and Internal Medicine from May 2022 to May 2023. Earlier career experience includes working as Assistant Director in Clinical Pharmacology/Experimental Medicine at GlaxoSmithKline from April 1998 to March 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices